Loading…

Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome

Up to 40% of patients with typical hemolytic-uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context of HUS, is...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2024-10, Vol.15, p.1469353
Main Authors: Wegener, Jamila, Dennhardt, Sophie, Loeffler, Ivonne, Coldewey, Sina M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c350t-c01767949698feb21893751a49b1d088dd8aa646767fff7d26db528e421379753
container_end_page
container_issue
container_start_page 1469353
container_title Frontiers in immunology
container_volume 15
creator Wegener, Jamila
Dennhardt, Sophie
Loeffler, Ivonne
Coldewey, Sina M
description Up to 40% of patients with typical hemolytic-uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context of HUS, is not yet fully understood. The objective of this study was to establish and characterize a Shiga toxin (Stx)-induced long-term HUS model to facilitate the study of mechanisms underlying the AKI-to-CKD transition. C57BL/6J mice were subjected to 5, 10, 15, or 20 ng/kg Stx on days 0, 3, and 6 of the experiment and were sacrificed on day 14 or day 21 to identify the critical time of turnover from the acute to the chronic state of HUS disease. Acute disease, indicated by weight loss, plasma neutrophil gelatinase-associated lipocalin (NGAL) and urea, and renal neutrophils, diminished after 14 days and returned to sham level after 21 days. HUS-associated hemolytic anemia transitioned to non-hemolytic microcytic anemia along with unchanged erythropoietin levels after 21 days. Renal cytokine levels indicated a shift towards pro-fibrotic signaling, and interstitial fibrosis developed concentration-dependently after 21 days. While Stx induced the intrarenal invasion of pro-inflammatory M1 and pro-fibrotic M2 macrophages after 14 days, pro-fibrotic M2 macrophages were the dominant phenotype after 21 days. In conclusion, we established and characterized the first Stx-induced long-term model of HUS. This tool facilitates the study of underlying mechanisms in the early AKI-to-CKD transition following HUS and allows the testing of compounds that may protect patients with AKI from developing subsequent CKD.
doi_str_mv 10.3389/fimmu.2024.1469353
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_832d975c548f473e910d7def973c8d7f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_832d975c548f473e910d7def973c8d7f</doaj_id><sourcerecordid>3120596308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-c01767949698feb21893751a49b1d088dd8aa646767fff7d26db528e421379753</originalsourceid><addsrcrecordid>eNpVkr1uHCEUhUdRothy_AIpIso0sx7-BqiiyMqPJUsu4tSIhcsumwEcmImyr5CnDvauLZsGxD3nu6c4XfceDytKpbrwIcZlRQbCVpiNinL6qjvF48h6Sgh7_ex90p3XuhvaYYpSyt92J1QxPmDBT7t_t8WkGuaQE_IlR2TsMgP6FVyCPQppt5Q9mjOy25JTsI8DFyqYCk2ADJpy2vQzlIjiUkICFLODCWWPfmzDxjT735D6kNxiwaEtxDzt52D7pUBsyLpPrm2Gd90bb6YK58f7rPv59cvt5ff--ubb1eXn695SPsy9bcFHoZgalfSwJlgqKjg2TK2xG6R0ThozsrGJvPfCkdGtOZHACKZCCU7PuqsD12Wz03clRFP2OpugHz5y2WhTWr4JtKTENYvlTHomKCg8OOHAK0GtdMI31qcD625ZR3AW0lzM9AL6cpLCVm_yH40xUwoz3Agfj4SSfy9QZx1DtTBNJkFeqqaYDFyNdJBNSg5SW3KtBfzTHjzo-1Loh1Lo-1LoYyma6cPzhE-WxwrQ_7kZtj8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120596308</pqid></control><display><type>article</type><title>Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome</title><source>Open Access: PubMed Central</source><creator>Wegener, Jamila ; Dennhardt, Sophie ; Loeffler, Ivonne ; Coldewey, Sina M</creator><creatorcontrib>Wegener, Jamila ; Dennhardt, Sophie ; Loeffler, Ivonne ; Coldewey, Sina M</creatorcontrib><description>Up to 40% of patients with typical hemolytic-uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context of HUS, is not yet fully understood. The objective of this study was to establish and characterize a Shiga toxin (Stx)-induced long-term HUS model to facilitate the study of mechanisms underlying the AKI-to-CKD transition. C57BL/6J mice were subjected to 5, 10, 15, or 20 ng/kg Stx on days 0, 3, and 6 of the experiment and were sacrificed on day 14 or day 21 to identify the critical time of turnover from the acute to the chronic state of HUS disease. Acute disease, indicated by weight loss, plasma neutrophil gelatinase-associated lipocalin (NGAL) and urea, and renal neutrophils, diminished after 14 days and returned to sham level after 21 days. HUS-associated hemolytic anemia transitioned to non-hemolytic microcytic anemia along with unchanged erythropoietin levels after 21 days. Renal cytokine levels indicated a shift towards pro-fibrotic signaling, and interstitial fibrosis developed concentration-dependently after 21 days. While Stx induced the intrarenal invasion of pro-inflammatory M1 and pro-fibrotic M2 macrophages after 14 days, pro-fibrotic M2 macrophages were the dominant phenotype after 21 days. In conclusion, we established and characterized the first Stx-induced long-term model of HUS. This tool facilitates the study of underlying mechanisms in the early AKI-to-CKD transition following HUS and allows the testing of compounds that may protect patients with AKI from developing subsequent CKD.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1469353</identifier><identifier>PMID: 39450175</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>acute kidney injury ; Acute Kidney Injury - chemically induced ; Acute Kidney Injury - etiology ; Acute Kidney Injury - pathology ; anemia ; animal model ; Animals ; chronic kidney disease ; Cytokines - metabolism ; Disease Models, Animal ; Disease Progression ; fibrosis ; hemolytic-uremic syndrome ; Hemolytic-Uremic Syndrome - chemically induced ; Hemolytic-Uremic Syndrome - etiology ; Immunology ; Kidney - pathology ; Lipocalin-2 ; Male ; Mice ; Mice, Inbred C57BL ; Renal Insufficiency, Chronic - etiology ; Shiga Toxin - toxicity</subject><ispartof>Frontiers in immunology, 2024-10, Vol.15, p.1469353</ispartof><rights>Copyright © 2024 Wegener, Dennhardt, Loeffler and Coldewey.</rights><rights>Copyright © 2024 Wegener, Dennhardt, Loeffler and Coldewey 2024 Wegener, Dennhardt, Loeffler and Coldewey</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c350t-c01767949698feb21893751a49b1d088dd8aa646767fff7d26db528e421379753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11499141/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11499141/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39450175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wegener, Jamila</creatorcontrib><creatorcontrib>Dennhardt, Sophie</creatorcontrib><creatorcontrib>Loeffler, Ivonne</creatorcontrib><creatorcontrib>Coldewey, Sina M</creatorcontrib><title>Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Up to 40% of patients with typical hemolytic-uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context of HUS, is not yet fully understood. The objective of this study was to establish and characterize a Shiga toxin (Stx)-induced long-term HUS model to facilitate the study of mechanisms underlying the AKI-to-CKD transition. C57BL/6J mice were subjected to 5, 10, 15, or 20 ng/kg Stx on days 0, 3, and 6 of the experiment and were sacrificed on day 14 or day 21 to identify the critical time of turnover from the acute to the chronic state of HUS disease. Acute disease, indicated by weight loss, plasma neutrophil gelatinase-associated lipocalin (NGAL) and urea, and renal neutrophils, diminished after 14 days and returned to sham level after 21 days. HUS-associated hemolytic anemia transitioned to non-hemolytic microcytic anemia along with unchanged erythropoietin levels after 21 days. Renal cytokine levels indicated a shift towards pro-fibrotic signaling, and interstitial fibrosis developed concentration-dependently after 21 days. While Stx induced the intrarenal invasion of pro-inflammatory M1 and pro-fibrotic M2 macrophages after 14 days, pro-fibrotic M2 macrophages were the dominant phenotype after 21 days. In conclusion, we established and characterized the first Stx-induced long-term model of HUS. This tool facilitates the study of underlying mechanisms in the early AKI-to-CKD transition following HUS and allows the testing of compounds that may protect patients with AKI from developing subsequent CKD.</description><subject>acute kidney injury</subject><subject>Acute Kidney Injury - chemically induced</subject><subject>Acute Kidney Injury - etiology</subject><subject>Acute Kidney Injury - pathology</subject><subject>anemia</subject><subject>animal model</subject><subject>Animals</subject><subject>chronic kidney disease</subject><subject>Cytokines - metabolism</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>fibrosis</subject><subject>hemolytic-uremic syndrome</subject><subject>Hemolytic-Uremic Syndrome - chemically induced</subject><subject>Hemolytic-Uremic Syndrome - etiology</subject><subject>Immunology</subject><subject>Kidney - pathology</subject><subject>Lipocalin-2</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Renal Insufficiency, Chronic - etiology</subject><subject>Shiga Toxin - toxicity</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkr1uHCEUhUdRothy_AIpIso0sx7-BqiiyMqPJUsu4tSIhcsumwEcmImyr5CnDvauLZsGxD3nu6c4XfceDytKpbrwIcZlRQbCVpiNinL6qjvF48h6Sgh7_ex90p3XuhvaYYpSyt92J1QxPmDBT7t_t8WkGuaQE_IlR2TsMgP6FVyCPQppt5Q9mjOy25JTsI8DFyqYCk2ADJpy2vQzlIjiUkICFLODCWWPfmzDxjT735D6kNxiwaEtxDzt52D7pUBsyLpPrm2Gd90bb6YK58f7rPv59cvt5ff--ubb1eXn695SPsy9bcFHoZgalfSwJlgqKjg2TK2xG6R0ThozsrGJvPfCkdGtOZHACKZCCU7PuqsD12Wz03clRFP2OpugHz5y2WhTWr4JtKTENYvlTHomKCg8OOHAK0GtdMI31qcD625ZR3AW0lzM9AL6cpLCVm_yH40xUwoz3Agfj4SSfy9QZx1DtTBNJkFeqqaYDFyNdJBNSg5SW3KtBfzTHjzo-1Loh1Lo-1LoYyma6cPzhE-WxwrQ_7kZtj8</recordid><startdate>20241010</startdate><enddate>20241010</enddate><creator>Wegener, Jamila</creator><creator>Dennhardt, Sophie</creator><creator>Loeffler, Ivonne</creator><creator>Coldewey, Sina M</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20241010</creationdate><title>Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome</title><author>Wegener, Jamila ; Dennhardt, Sophie ; Loeffler, Ivonne ; Coldewey, Sina M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-c01767949698feb21893751a49b1d088dd8aa646767fff7d26db528e421379753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute kidney injury</topic><topic>Acute Kidney Injury - chemically induced</topic><topic>Acute Kidney Injury - etiology</topic><topic>Acute Kidney Injury - pathology</topic><topic>anemia</topic><topic>animal model</topic><topic>Animals</topic><topic>chronic kidney disease</topic><topic>Cytokines - metabolism</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>fibrosis</topic><topic>hemolytic-uremic syndrome</topic><topic>Hemolytic-Uremic Syndrome - chemically induced</topic><topic>Hemolytic-Uremic Syndrome - etiology</topic><topic>Immunology</topic><topic>Kidney - pathology</topic><topic>Lipocalin-2</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Renal Insufficiency, Chronic - etiology</topic><topic>Shiga Toxin - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wegener, Jamila</creatorcontrib><creatorcontrib>Dennhardt, Sophie</creatorcontrib><creatorcontrib>Loeffler, Ivonne</creatorcontrib><creatorcontrib>Coldewey, Sina M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wegener, Jamila</au><au>Dennhardt, Sophie</au><au>Loeffler, Ivonne</au><au>Coldewey, Sina M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2024-10-10</date><risdate>2024</risdate><volume>15</volume><spage>1469353</spage><pages>1469353-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Up to 40% of patients with typical hemolytic-uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context of HUS, is not yet fully understood. The objective of this study was to establish and characterize a Shiga toxin (Stx)-induced long-term HUS model to facilitate the study of mechanisms underlying the AKI-to-CKD transition. C57BL/6J mice were subjected to 5, 10, 15, or 20 ng/kg Stx on days 0, 3, and 6 of the experiment and were sacrificed on day 14 or day 21 to identify the critical time of turnover from the acute to the chronic state of HUS disease. Acute disease, indicated by weight loss, plasma neutrophil gelatinase-associated lipocalin (NGAL) and urea, and renal neutrophils, diminished after 14 days and returned to sham level after 21 days. HUS-associated hemolytic anemia transitioned to non-hemolytic microcytic anemia along with unchanged erythropoietin levels after 21 days. Renal cytokine levels indicated a shift towards pro-fibrotic signaling, and interstitial fibrosis developed concentration-dependently after 21 days. While Stx induced the intrarenal invasion of pro-inflammatory M1 and pro-fibrotic M2 macrophages after 14 days, pro-fibrotic M2 macrophages were the dominant phenotype after 21 days. In conclusion, we established and characterized the first Stx-induced long-term model of HUS. This tool facilitates the study of underlying mechanisms in the early AKI-to-CKD transition following HUS and allows the testing of compounds that may protect patients with AKI from developing subsequent CKD.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>39450175</pmid><doi>10.3389/fimmu.2024.1469353</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2024-10, Vol.15, p.1469353
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_832d975c548f473e910d7def973c8d7f
source Open Access: PubMed Central
subjects acute kidney injury
Acute Kidney Injury - chemically induced
Acute Kidney Injury - etiology
Acute Kidney Injury - pathology
anemia
animal model
Animals
chronic kidney disease
Cytokines - metabolism
Disease Models, Animal
Disease Progression
fibrosis
hemolytic-uremic syndrome
Hemolytic-Uremic Syndrome - chemically induced
Hemolytic-Uremic Syndrome - etiology
Immunology
Kidney - pathology
Lipocalin-2
Male
Mice
Mice, Inbred C57BL
Renal Insufficiency, Chronic - etiology
Shiga Toxin - toxicity
title Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A25%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transition%20from%20acute%20kidney%20injury%20to%20chronic%20kidney%20disease%20in%20a%20long-term%20murine%20model%20of%20Shiga%20toxin-induced%20hemolytic-uremic%20syndrome&rft.jtitle=Frontiers%20in%20immunology&rft.au=Wegener,%20Jamila&rft.date=2024-10-10&rft.volume=15&rft.spage=1469353&rft.pages=1469353-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1469353&rft_dat=%3Cproquest_doaj_%3E3120596308%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-c01767949698feb21893751a49b1d088dd8aa646767fff7d26db528e421379753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3120596308&rft_id=info:pmid/39450175&rfr_iscdi=true